Movatterモバイル変換

[0]ホーム
URL:

Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Nature Publishing Group full text link Nature Publishing Group Free PMC article
Full text links

Actions

Share

.2017 Jan;14(1):75-82.
doi: 10.1038/nmeth.4057. Epub 2016 Nov 7.

DMS-MaPseq for genome-wide or targeted RNA structure probing in vivo

Affiliations

DMS-MaPseq for genome-wide or targeted RNA structure probing in vivo

Meghan Zubradt et al. Nat Methods.2017 Jan.

Abstract

Coupling of structure-specific in vivo chemical modification to next-generation sequencing is transforming RNA secondary structure studies in living cells. The dominant strategy for detecting in vivo chemical modifications uses reverse transcriptase truncation products, which introduce biases and necessitate population-average assessments of RNA structure. Here we present dimethyl sulfate (DMS) mutational profiling with sequencing (DMS-MaPseq), which encodes DMS modifications as mismatches using a thermostable group II intron reverse transcriptase. DMS-MaPseq yields a high signal-to-noise ratio, can report multiple structural features per molecule, and allows both genome-wide studies and focused in vivo investigations of even low-abundance RNAs. We apply DMS-MaPseq for the first analysis of RNA structure within an animal tissue and to identify a functional structure involved in noncanonical translation initiation. Additionally, we use DMS-MaPseq to compare the in vivo structure of pre-mRNAs with their mature isoforms. These applications illustrate DMS-MaPseq's capacity to dramatically expand in vivo analysis of RNA structure.

PubMed Disclaimer

Conflict of interest statement

Competing Financial Interests

Thermostable group II intron reverse transcriptase (TGIRT) enzymes and methods for their use are the subject of patents and patent applications that have been licensed by the University of Texas and East Tennessee State University to InGex, LLC. A.M.L. and the University of Texas are minority equity holders in InGex, LLC and receive royalty payments from the sale of TGIRT enzymes and the licensing of intellectual property. The other authors declare no competing financial interests.

Figures

Figure 1
Figure 1. Sequencing library generation for RNA structure probing techniques
Schematic of library preparation strategies for cDNA truncation approaches(a) and for DMS-MaPseq(b).
Figure 2
Figure 2. TGIRT enzyme delivers higher signal and lower background for DMS-MaPseq
a, Distribution of mutation type generated by SSII/Mn2+ or TGIRT reverse transcription fromin vivo DMS-treated yeast mRNA.b, Endogenous m1A modifications in yeast 25S rRNA transcript reveal superior modification detection with TGIRT. Average percent modification (bar) detected at the position across two biological DMS-treated replicates (circles) with error bars representing standard deviation from the average.c, Nucleotide composition of mismatches from TGIRT or SSII/Mn2+ approaches.d, YeastRPS28B mRNA positive control structure with nucleotides colored by DMS reactivityin vivo. Black boxes outline G/U bases with high background signal. DMS reactivity was calculated as the average ratiometric DMS signal per position across two biological replicates normalized to the highest number of reads in displayed region, which is set to 1.0.e, Genome-wide DMS-MaPseq replicates compared by Pearson’sr value and Gini index for yeast mRNA regions (requiring 15x coverage, resulting in 733 and 272 regions displayed for TGIRT and SSII/Mn2+, respectively).
Figure 3
Figure 3. Global analysis ofin vivo DMS-MaPseq data
a, Signal decay observed after endogenous m1A modification at position 642 in the yeast 25S rRNA in DMS-seq, but not in DMS-MaPseq.b, Histogram of ratiometric reactivity for negative control bases in the yeast 18S rRNA. The total number of negative control bases is 338, characterized as bases known to be base-paired.c, Scatterplot of GC content versus Gini Index in 50nt windows of deeply sequenced genes. Non-coding RNA regions include UTRs and all classes of mammalian non-coding RNAs. The total number of evaluated windows is 182. Pearson’s correlation = 0.32, p-value = 7.3e-6.
Figure 4
Figure 4. DMS-MaPseq enablesin vivo RNA structure probing for specific RNA targets
a, Cumulative histogram of Pearson’sr values between yeast mRNA regions in DMS-MaPseq replicates at varied depths of average mismatch coverage.b, Fraction of genes exceeding the minimum average mismatch coverage of 20x in genome-wide human HEK 293T DMS-MaPseq data with varied sequencing depths. 0.006, 0.009, and 0.03 are the fraction of genes passing this threshold at 50, 100, and 200 million uniquely mapped reads, respectively.c, Schematic for targeted RNA structure probing via target-specific RT-PCR and NexteraXT tagmentation.d, ROC curve for DMS signal on yeast 18S rRNA using ratiometric data from target-specific tagmentation approach and from genome-wide DMS-MaPseq.e, f, YeastHAC1 (e) andRPS28B (f) 3′ UTR mRNA positive control structures from target-specific priming with nucleotides colored by DMS reactivityin vivo. DMS reactivity calculated as the ratiometric DMS signal per position normalized to the highest number of reads in displayed region, which is set to 1.0.
Figure 5
Figure 5. Novel experimental applications forin vivo RNA structure probing
a,oskar 3′ UTR mRNA positive control structure from target-specific priming with nucleotides colored byin vivo DMS reactivity in D. melanogaster ovaries. DMS reactivity calculated as the ratiometric DMS signal per position normalized to the highest number of reads in displayed region, which is set to 1.0.b,oskar positive control region from (a) shown with average normalized DMS-MaPseq values from two biological replicates, one at 5 min DMS treatment and one at 10 min. Error bars represent one standard deviation.c, Ratiometric DMS-MaPseq from targeted amplification of the humanFXR2 5′ UTR and exon1 sequence. Nucleotides accessible to DMS are noted with a value >0.03, which is the threshold representing the best agreement with our model. Position 1 corresponds to chromosome XVII:7614897.
Figure 6
Figure 6. Investigating RNA structure heterogeneity with DMS-MaPseq
a, Regions of heterogeneous structure exhibit indistinguishable structure signals when combined but can be distinguished by DMS-MaPseq, illustrated by normalized DMS-MaPseq data derived from the human MRPS21 ribosnitch A/C alleles. Allele-specific data represented as the mean of three technical replicates. Error bars represent one standard deviation.b, Targeted DMS-MaPseq data specific for the yeast RPL14A pre-mRNA and spliced mRNA isoforms reveal minimal structure difference in the common exon1 sequence (r = 0.88). Ratiometricin vivo DMS-MaPseq data is plotted with isoform-specific RT primer locations noted with arrows.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Mortimer SA, Kidwell MA, Doudna JA. Insights into RNA structure and function from genome-wide studies. Nat Rev Genet. 2014;15:469–479. - PubMed
    1. Deigan KE, Li TW, Mathews DH, Weeks KM. Accurate SHAPE-directed RNA structure determination. Proc Natl Acad Sci U S A. 2009;106:97–102. - PMC - PubMed
    1. Ouyang Z, Snyder MP, Chang HY. SeqFold: genome-scale reconstruction of RNA secondary structure integrating high-throughput sequencing data. Genome Res. 2013;23:377–387. - PMC - PubMed
    1. Rouskin S, Zubradt M, Washietl S, Kellis M, Weissman JS. Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo. Nature. 2014;505:701–705. - PMC - PubMed
    1. Wells SE, Hughes JM, Igel AH, Ares M., Jr Use of dimethyl sulfate to probe RNA structure in vivo. Methods Enzymol. 2000;318:479–493. - PubMed

Online Methods References

    1. Zubradt M, et al. Genome-wide DMS-MaPseq for in vivo RNA structure determination. Protoc Exch. 2016http://dx.doi.org/10.1038/protex.2016.068. - DOI
    1. Zubradt M, et al. Target-specific DMS-MaPseq for in vivo RNA structure determination. Protoc Exch. 2016http://dx.doi.org/10.1038/protex.2016.069. - DOI
    1. Rouskin S, Zubradt M, Washietl S, Kellis M, Weissman JS. Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo. Nature. 2014;505:701–705. - PMC - PubMed
    1. Ingolia NT, Ghaemmaghami S, Newman JRS, Weissman JS. Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling. Science. 2009;324:218–223. - PMC - PubMed
    1. Homan PJ, et al. Single-molecule correlated chemical probing of RNA. Proc Natl Acad Sci U S A. 2014;111:13858–13863. - PMC - PubMed

Publication types

MeSH terms

Substances

Related information

Grants and funding

LinkOut - more resources

Full text links
Nature Publishing Group full text link Nature Publishing Group Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.

[8]ページ先頭
©2009-2025 Movatter.jp